Skip to Content

Amphora Approval Status

  • FDA approved: No
  • Brand name: Amphora
  • Generic name: L-lactic acid, citric acid, and potassium bitartrate
  • Dosage form: Vaginal Gel
  • Company: Evofem, Inc.
  • Treatment for: Birth Control

Amphora (L-lactic acid, citric acid, and potassium bitartrate) is a non-hormonal vaginal gel in development for use as a contraceptive, and for the prevention of urogenital chlamydia in women.

Development Status and FDA Approval Process for Amphora

Feb 21, 2018Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia
Sep 22, 2015Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora as a Contraceptive
Jul  6, 2015Evofem, Inc. Submits NDA to U.S. FDA for Amphora as a Contraceptive

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.